Hill Stephen J.

Chief Operating Officer

Hill Stephen J. has filed 6 SEC Form 4 filings (7 transaction rows) across 1 company, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Aug 25, 2026.

On the most recent filing, Hill Stephen J. is listed as Chief Operating Officer at Lyell Immunopharma, Inc. Inside the rolling window, Hill Stephen J. reported no open-market purchases and 6 open-market sales totaling $51K in LYEL. The largest disclosed transaction in the window is a sale of 1,236 LYEL shares on Feb 11, 2026, worth $29K.

Companies traded

Other insiders at LYEL

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$51K

reported sales (SEC code S)

Companies

1

in the rolling window

Source
LYELSale$15KAug 25SEC ↗
LYELSale$1KAug 11SEC ↗
LYELSale$2KJun 15SEC ↗
LYELSale$29KFeb 12SEC ↗
LYELSale$3KFeb 11SEC ↗
LYELSale$2KNov 12SEC ↗
Showing 1–6 of 6
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Hill Stephen J. made?

Hill Stephen J. has filed 6 SEC Form 4 filings (7 transaction rows) across 1 company since 2025.

Which companies does Hill Stephen J. trade?

Hill Stephen J. has filed SEC Form 4 disclosures for 1 company, including LYEL.

When was Hill Stephen J.'s most recent SEC Form 4 filing?

Hill Stephen J.'s most recent SEC Form 4 filing on Tracefour is dated Aug 25, 2026.

What is Hill Stephen J.'s job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Hill Stephen J. is listed as Chief Operating Officer.

What is Hill Stephen J.'s total buy and sell value in the current window?

Inside the rolling retention window, Hill Stephen J. bought $0 and sold $51K based on SEC Form 4 filings.

What was Hill Stephen J.'s largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 1,236 LYEL shares on 2026-02-11, worth $29K, per SEC Form 4 filings.